Antitumor effect of vandetanib through EGFR inhibition in head and neck squamous cell carcinoma

Abstract

We demonstrated that vandetanib inhibits the growth of head and neck cancer cell lines. The antitumor effects of vandetanib appear to be exerted via the EGFR inhibitory effect of the compound.